Contrast-enhanced Harmonic Compound US of the Spleen to Increase Staging Accuracy in Patients with Hodgkin Lymphoma: A Prospective Study
Authors:
- Marco PicardiMarco Picardi
- Andrea SoricelliASAndrea Soricelli
- Fabrizio PaneFPFabrizio Pane
- Pio ZeppaPZPio Zeppa
- Emanuele NicolaiENEmanuele Nicolai
- Michele De LaurentiisMichele De Laurentiis
- Francesco GrimaldiFrancesco Grimaldi
- Bruno RotoliBRBruno Rotoli
- 1 May 2009
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 251 (2) , 574-582
Abstract
To prospectively compare contrast material-enhanced harmonic compound ultrasonography (US), computed tomography (CT), and fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET) in detecting nodular infiltration in the spleen of patients with newly diagnosed Hodgkin lymphoma. After institutional review board approval and informed consent, 100 consecutive patients with Hodgkin lymphoma during pretreatment staging were prospectively investigated for possible spleen involvement by comparing harmonic compound US (integrated with intravenous infusion of microbubbles in 33 patients) with CT and FDG PET. Findings indicative of malignant nodules with the imaging procedures were regarded as lymphoma infiltration; in case of discrepancy, response to treatment was regarded as evidence of lymphoma. Malignant nodules were detected with CT in 13 patients, with FDG PET in 13 patients, and with contrast-enhanced harmonic compound US in 30 patients. Coincidental findings of malignancy with all three imaging techniques occurred in 13 patients; 17 patients had only US-detectable malignant nodules, which showed disappearance or relevant decrease after chemotherapy. Overall, the spleen had nodular infiltration in 30 patients (13 for imaging finding concordance; 17 for typical contrast-enhanced harmonic compound US findings and chemotherapy-related nodule size modifications). Thus, both CT and FDG PET provided false-negative results in 17 of 30 patients compared with contrast-enhanced harmonic compound US, the results of which translated into disease upstaging in 13 patients. Harmonic compound US with contrast enhancement for the characterization of possible nodules provides a higher sensitivity than does CT or FDG PET in the detection of splenic involvement by Hodgkin lymphoma.Keywords
This publication has 23 references indexed in Scilit:
- New perspectives for the use of contrast-enhanced liver ultrasound in clinical practiceDigestive and Liver Disease, 2007
- Characterization of Focal Liver Lesions with Contrast-specific US Modes and a Sulfur Hexafluoride–filled Microbubble Contrast Agent: Diagnostic Performance and ConfidenceRadiology, 2004
- Evidence for Spleen-specific Uptake of a Microbubble Contrast Agent: A Quantitative Study in Healthy VolunteersRadiology, 2004
- Comparison of Conventional Sonography, Real-Time Compound Sonography, Tissue Harmonic Sonography, and Tissue Harmonic Compound Sonography of Abdominal and Pelvic LesionsAmerican Journal of Roentgenology, 2003
- Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasoundEuropean Radiology, 2001
- Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.Journal of Clinical Oncology, 1993
- Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.Journal of Clinical Oncology, 1989
- Subdiaphragmatic Hodgkin's disease: laparotomy and treatment results in 49 patients.Journal of Clinical Oncology, 1987
- Hodgkin's disease presenting below the diaphragm: a review.Journal of Clinical Oncology, 1986
- The value of laparotomy and splenectomy in the staging of Hodgkin's diseaseCancer, 1969